Suppr超能文献

医生对“需治疗人数”(NNT)的认知。一项关于医生对两种具有不同NNT的疗法的推荐情况的调查。

Medical doctors' perception of the "number needed to treat" (NNT). A survey of doctors' recommendations for two therapies with different NNT.

作者信息

Halvorsen Peder Andreas, Kristiansen Ivar Sønbø, Aasland Olaf Gjerløw, Førde Olav Helge

机构信息

Institute of Community Medicine, University of Tromsø, Tromsø, Norway.

出版信息

Scand J Prim Health Care. 2003 Sep;21(3):162-6. doi: 10.1080/02813430310001158.

Abstract

OBJECTIVE

While the number needed to treat (NNT) is in widespread use, empirical evidence that doctors or patients interpret the NNT adequately is sparse. The aim of our study was to explore the influence of the NNT on medical doctors' recommendation for or against a life-long preventive drug therapy.

DESIGN

Cross-sectional study with randomisation to different scenarios.

SETTING

Postal questionnaire presenting a clinical scenario about a hypothetical drug as a strategy towards preventing premature death among healthy people with a known risk factor. Benefit after 5 years of treatment was presented in terms of NNT, which was set at 50 for half of the respondents and 200 for the other half.

SUBJECTS

Representative sample (n = 1616) of Norwegian medical doctors.

MAIN OUTCOME MEASURES

Proportion of doctors that would prescribe the drug. Reasons for recommending against the therapy.

RESULTS

With NNT set at 50, 71.6% (99% CI 66.8-76.4) of the doctors would prescribe the drug, while the proportion was 52.3% (99% CI 47.5-57.1) with an NNT of 200 (chi = 50.7, p < 0.001). Multivariate logistic regression analysis indicated that the effect of NNT on the likelihood for recommending the therapy was age-dependent; young doctors ( < 36 of age) were more sensitive to the difference in NNTs than older doctors. Thirty-six percent (n = 464) of the doctors would not prescribe the drug, and 77.4% (99% CI 68.5-86.2) of those agreed with an argument stating that only one out of NNT patients would benefit from the treatment.

CONCLUSION

Medical doctors appear to be sensitive to the magnitude of the NNT in their clinical recommendations. However, many doctors believe that only one out of NNT patients benefits from therapy. Clinical recommendations based on this assumption may be misleading.

摘要

目的

虽然需治疗人数(NNT)被广泛使用,但关于医生或患者能否充分理解NNT的实证证据却很少。我们研究的目的是探讨NNT对医生推荐或反对终身预防性药物治疗的影响。

设计

采用随机分配至不同场景的横断面研究。

设置

通过邮政问卷呈现一个关于一种假设药物的临床场景,该药物作为预防具有已知风险因素的健康人过早死亡的策略。以NNT来表示5年治疗后的益处,对一半的受访者设定NNT为50,对另一半设定为200。

研究对象

挪威医生的代表性样本(n = 1616)。

主要观察指标

会开具该药物的医生比例。反对该治疗的原因。

结果

当NNT设定为50时,71.6%(99%可信区间66.8 - 76.4)的医生会开具该药物,而当NNT为200时,这一比例为52.3%(99%可信区间47.5 - 57.1)(χ² = 50.7,p < 0.001)。多因素逻辑回归分析表明,NNT对推荐治疗可能性的影响取决于年龄;年轻医生(年龄<36岁)比年长医生对NNT差异更敏感。36%(n = 464)的医生不会开具该药物,其中77.4%(99%可信区间68.5 - 86.2)同意这样一种观点,即NNT患者中只有一人会从治疗中获益。

结论

医生在临床推荐中似乎对NNT的大小很敏感。然而,许多医生认为NNT患者中只有一人能从治疗中获益。基于这一假设的临床推荐可能会产生误导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验